Here, we demonstrate that neither of the HCC tissues, responder and non-responder to galunisertib effectiveness in vitro according to our previous investigation,15 contained the somatic mutations most frequently found in HCCs, such as TERT or TP53 mutations.21 Here, TERT is linked to hepatocellular carcinoma.